


Tandem Therapeutics Revenue
Biotechnology Research • Schlieren, Zurich, Switzerland • 1-10 Employees
Tandem Therapeutics revenue & valuation
| Annual revenue | $427,775 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $1,400,000 |
| Total funding | No funding |
Key Contact at Tandem Therapeutics
Jodi Williams
Director, Medicinal Chemistry
Company overview
| Headquarters | Wagistrasse 18, Schlieren, 8952, CH |
| Website | |
| NAICS | 541714 |
| Founded | 2023 |
| Employees | 1-10 |
| Socials |
Tandem Therapeutics Email Formats
Tandem Therapeutics uses 1 email format. The most common is {first name}.{last name} (e.g., john.doe@tandem-tx.com), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@tandem-tx.com | 100% |
About Tandem Therapeutics
TANDEM Therapeutics is a discovery stage Swiss biopharmaceutical company bringing a novel precision targeting approaches to fibrosis and fibrotic cancers. We advance over 15 years of transformative research and development at ETH Zürich and Paul Scherrer Institut in the field of extracellular matrix biology and the critical role it plays in the pathology of fibrotic cancers & organ fibrosis. The therapeutic platform is based on Matrix Targeting Peptides (MTP) that conditionally target disease associated matrix alterations that are known to be directly associated with several fibrotic diseases.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Tandem Therapeutics Tech Stack
Discover the technologies and tools that power Tandem Therapeutics's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
Tag managers
Reverse proxies
Miscellaneous
Programming languages
Miscellaneous
Security
Video players
Analytics
Frequently asked questions
4.8
40,000 users



